...
首页> 外文期刊>British Journal of Pharmacology >Different subtypes of α_(1A)-adrenoceptor mediating contraction of rat epididymal vas deferens, rat hepatic portal vein and human prostate distinguished by the antagonist RS 17053
【24h】

Different subtypes of α_(1A)-adrenoceptor mediating contraction of rat epididymal vas deferens, rat hepatic portal vein and human prostate distinguished by the antagonist RS 17053

机译:通过拮抗剂RS 17053区分不同的亚型α_(1A)-肾上腺素能受体介导大鼠附睾输精管,大鼠肝门静脉和人前列腺的收缩

获取原文
获取原文并翻译 | 示例

摘要

1 The α_1-adrenoceptor subtype mediating contraction of the rat hepatic portal vein to phenylephrine was characterized by use of competitive antagonists previously shown to have selectivity between the expressed α_1-subtype clones. Prazosin competitively antagonized the phenylephrine contractions with a pA_2 value of 9.2, as did WB 4101 (pA_2 9.4), 5-methyl urapidil (pA_2 8.6), indoramin (pA_2 8.4) and BMY 7378 (pA_2 6.5). 2 The pA_2 values on the rat portal vein correlated highly with their previously published pA_2 values for the α_(1A)-adrenoceptors mediating contraction of the rat epididymal vas deferens and human prostate and poorly with those for the α_(1B)- and α_(1D)-adrenoceptors mediating contraction of the rat spleen and aorta, respectively. The antagonist pA_2 values on the rat portal vein correlated highly with their previously published pK_1 values for the expressed α_(1a)-clone and poorly with those for the expressed α_(1b)- and α_(1d)-clones. Therefore the results show that contraction of the rat portal vein to phenylephrine is mediated by α_(1A)-adrenoceptors. 3 The novel α_1-adrenoceptor antagonist RS 17053 had a relatively high affinity for the α_(1A)-adrenoceptors mediating contraction of the rat epididymal vas deferens (pA_2 9.5) compared with the α_(1B)-adrenoceptors in the rat spleen (pA_2 7.2) or the α_(1D)-adrenoceptors in the rat aorta (pK_B 7.1), in agreement with its selectivity for the expressed α_(1a)-clone. However, RS 17053 had over 100 fold lower affinity for the α_(1A)-adrenoceptors mediating contraction of the rat portal vein (pK_B 7.1) and human prostate (pK_B 7.1) compared with its affinity for the α_(1A)-adrenoceptors in the rat epididymal vas deferens or the expressed α_(1a)-clone. 4 The difference in affinity of RS 17053 between the rat epididymal vas deferens and rat portal vein cannot be explained by a species difference in the receptor. Therefore RS 17053 may distinguish between subtypes of the α_(1A)-adrenoceptor in the rat portal vein and human prostate compared with those in the rat epididymal vas deferens or the expressed α_(1a)-clone.
机译:1介导大鼠肝门静脉收缩至去氧肾上腺素的α_1-肾上腺素能受体亚型的特征在于使用竞争性拮抗剂,以前显示在表达的α_1-亚型克隆之间具有选择性。与WB 4101(pA_2 9.4),5-甲基尿嘧啶(pA_2 8.6),吲哚胺(pA_2 8.4)和BMY 7378(pA_2 6.5)一样,普拉唑嗪竞争性拮抗苯肾上腺素的收缩,其pA_2值为9.2。 2大鼠门静脉的pA_2值与先前公布的介导大鼠附睾输精管和人前列腺收缩的α_(1A)-肾上腺素能受体的pA_2值高度相关,而与α_(1B)-和α_( 1D)-肾上腺素能受体分别介导大鼠脾脏和主动脉的收缩。大鼠门静脉上的拮抗剂pA_2值与先前发表的表达的α_(1a)克隆的pK_1值高度相关,而与表达的α_(1b)-和α_(1d)克隆的pK_1值相关性较低。因此结果表明,大鼠门静脉向去氧肾上腺素的收缩是由α_(1A)-肾上腺素受体介导的。 3与介导大鼠附睾输精管收缩的α_(1A)肾上腺素受体(pA_2 9.5)相比,新型α_1-肾上腺素受体拮抗剂RS 17053与大鼠脾脏中的α_(1B)-肾上腺素受体(pA_2 7.2)具有相对较高的亲和力)或大鼠主动脉中的α_(1D)-肾上腺素能受体(pK_B 7.1),与其对表达的α_(1a)克隆的选择性一致。然而,RS 17053对介导大鼠门静脉(pK_B 7.1)和人前列腺(pK_B 7.1)收缩的α_(1A)-肾上腺素受体的亲和力比其对α_(1A)-肾上腺素受体的亲和力低100倍以上。大鼠附睾输精管或表达的α_(1a)-克隆。 4大鼠附睾输精管与大鼠门静脉之间RS 17053亲和力的差异无法通过受体的物种差异来解释。因此,与大鼠附睾输精管或表达的α_(1a)克隆相比,RS 17053可以区分大鼠门静脉和人前列腺中的α_(1A)-肾上腺素受体亚型。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号